Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis

Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis

Abstract Background Lack of understanding of interstitial lung disease (ILD) associated with systemic sclerosis (SSc) and rheumatoid arthritis (RA) hinders the early and accurate identification of these devastating diseases. Current clinical tools limitations highlight the need to complement them wi...

Full description

Bibliographic Details
Main Authors: Verónica Pulito-Cueto, Belén Atienza-Mateo, Joao C. Batista-Liz, María Sebastián Mora-Gil, Víctor M. Mora-Cuesta, David Iturbe-Fernández, Sheila Izquierdo Cuervo, Carolina Aguirre Portilla, Ricardo Blanco, Raquel López-Mejías
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Molecular Medicine
Subjects:
Matrix metalloproteinases
Matrix metalloproteinases tissue inhibitors
Interstitial lung disease
Autoimmune diseases
Rheumatoid arthritis
Systemic sclerosis
Online Access:https://doi.org/10.1186/s10020-025-01128-2

Internet

https://doi.org/10.1186/s10020-025-01128-2

Similar Items